Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind placebo-controlled study of sivopixant in refractory chronic cough
jRCT2080224991Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in refractory chronic cough (RCC) and chronic idiopathic cough (CIC) comparing sivopixant with placebo (2 arms). Started Dec 2019; status: completed.
02
Drugs
sivopixant
03
Conditions
refractory chronic cough (RCC)chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on jRCT2080224991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224991.